Key facts
- Aide Health’s last known valuation is $8.2M (Feb 2025).
- It has raised $2.8M; the latest was Accelerator/Incubator in Apr 2025.
- Notable investors include Fuel Ventures, Salica Investments, ABHI US Accelerator, 1818 Venture Capital, Deuce Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Aide Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Aide Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aide Health
Developer of a digital health service platform designed to strengthen the relationship between clinicians and their patients. The company uses conversational artificial intelligence to improve patient engagement and clinical assessment for chronic disease and help manage day-to-day activities and form positive habits, enabling patients to get a true picture of their health and make proactive decisions to avoid complications and exacerbations.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2021
- Employees
- 8
- Website
- aide.health/
- Ownership
- Privately Held (backing)
Aide Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aide Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aide Health in its N-PORT filings yet. We sweep new filings monthly.